Atlassian (NASDAQ:TEAM) CEO Michael Cannon-Brookes Sells 7,665 Shares

Atlassian Corporation PLC (NASDAQ:TEAM) CEO Michael Cannon-Brookes sold 7,665 shares of the stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $94.81, for a total value of $726,718.65. Following the completion of the transaction, the chief executive officer owned 275,940 shares in the company, valued at approximately $26,161,871.40. The trade was a 2.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Michael Cannon-Brookes also recently made the following trade(s):

• On Wednesday, February 4th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $105.14, for a total transaction of $805,898.10.
• On Monday, February 2nd, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $116.40, for a total transaction of $892,206.00.
• On Friday, January 30th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $119.15, for a total transaction of $913,284.75.
• On Wednesday, January 28th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $135.44, for a total value of $1,038,147.60.
• On Monday, January 26th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $136.93, for a total value of $1,049,568.45.
• On Thursday, January 22nd, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $126.11, for a total value of $966,633.15.
• On Tuesday, January 20th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $118.19, for a total value of $905,926.35.
• On Friday, January 16th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $120.82, for a total transaction of $926,085.30.
• On Wednesday, January 14th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $133.66, for a total transaction of $1,024,503.90.
• On Monday, January 12th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $147.15, for a total transaction of $1,127,904.75.

Atlassian Trading Down 3.7%

Shares of Atlassian stock opened at $94.72 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.26 and a current ratio of 1.26. The company has a market capitalization of $24.92 billion, a P/E ratio of -131.55, a PEG ratio of 15.24 and a beta of 0.88. Atlassian Corporation PLC has a 1 year low of $92.32 and a 1 year high of $326.00. The company’s fifty day moving average is $144.50 and its two-hundred day moving average is $158.46.

Atlassian (NASDAQ:TEAM) last announced its earnings results on Thursday, February 5th. The technology company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.12 by $0.10. Atlassian had a negative net margin of 3.29% and a negative return on equity of 6.60%. The business had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.54 billion. During the same quarter in the prior year, the firm earned $0.96 earnings per share. The business’s quarterly revenue was up 23.3% compared to the same quarter last year. Analysts forecast that Atlassian Corporation PLC will post -0.34 earnings per share for the current year.

Key Headlines Impacting Atlassian

Here are the key news stories impacting Atlassian this week:

• Positive Sentiment: Q2 beat — Atlassian reported $1.22 EPS vs. $1.12 expected and revenue of $1.59B (vs. $1.54B est.), with revenue up ~23% y/y, a near-term fundamental positive for growth momentum. Atlassian Q2 Earnings Surpass Expectations
• Positive Sentiment: Management raised its fiscal 2026 revenue forecast, citing resilient enterprise spending and accelerating AI adoption — supports the company’s multi-quarter revenue outlook. Atlassian Raises Annual Revenue Forecast (Reuters)
• Positive Sentiment: Company targets 20%+ annual revenue growth through FY27 and cites record cloud revenue and AI integrations — a constructive strategic signal if execution continues. Seeking Alpha: Growth Target
• Positive Sentiment: Unusual options activity — a spike to ~14,021 calls purchased (≈51% above normal), which can indicate tactical bullish positioning by traders.
• Neutral Sentiment: Analysts trimmed price targets but kept favorable ratings (Morgan Stanley, Mizuho, BTIG among others) — reduces near-term implied upside but preserves buy/overweight bias. Benzinga: Analyst Target Changes
• Negative Sentiment: Insider selling — directors/co‑founders disclosed multiple recent sales (7,665 shares each), a visible negative for investor sentiment and a factor pressuring the stock. SEC Filing: Insider Sales
• Negative Sentiment: Cantor Fitzgerald and some other brokers cut price targets sharply (e.g., Cantor to $146), and sector-wide AI fears are amplifying downside pressure. Cantor Fitzgerald Target Cut
• Negative Sentiment: Market reaction: coverage notes shares dipped despite the beat as investors worry cloud growth may slow and AI competition/feature rollouts elsewhere increase volatility. Investing.com: Shares Dip

Wall Street Analyst Weigh In

TEAM has been the subject of several analyst reports. Robert W. Baird set a $140.00 price target on Atlassian in a research note on Friday. Truist Financial set a $210.00 price objective on shares of Atlassian in a research report on Friday, October 31st. Cantor Fitzgerald lowered their target price on shares of Atlassian from $240.00 to $146.00 and set an “overweight” rating on the stock in a report on Wednesday. KeyCorp dropped their price target on shares of Atlassian from $210.00 to $170.00 and set an “overweight” rating on the stock in a research note on Friday. Finally, Sanford C. Bernstein increased their price target on shares of Atlassian from $290.00 to $304.00 and gave the stock an “outperform” rating in a report on Tuesday, November 18th. Twenty equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Atlassian presently has a consensus rating of “Moderate Buy” and an average target price of $191.32.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC increased its holdings in Atlassian by 252.9% in the fourth quarter. EverSource Wealth Advisors LLC now owns 7,689 shares of the technology company’s stock valued at $1,247,000 after buying an additional 5,510 shares in the last quarter. Evoke Wealth LLC acquired a new stake in shares of Atlassian in the 4th quarter worth approximately $896,000. Tensor Edge Capital LLC acquired a new stake in shares of Atlassian in the 4th quarter worth approximately $5,028,000. Mach 1 Financial Group LLC purchased a new position in Atlassian in the 4th quarter valued at approximately $210,000. Finally, Fi3 FINANCIAL ADVISORS LLC acquired a new position in Atlassian during the fourth quarter worth $543,000. 94.45% of the stock is currently owned by institutional investors and hedge funds.

Atlassian Company Profile

Atlassian Corporation Plc is a software company headquartered in Sydney, Australia, best known for developing collaboration, project management and software development tools. Founded in 2002 by Mike Cannon-Brookes and Scott Farquhar, Atlassian grew from a small engineering-focused team into a publicly traded company after its initial public offering in 2015. The company serves a global customer base that spans small teams to large enterprises across technology, financial services, government and other sectors.

Atlassian’s product portfolio centers on tools designed to help teams plan, build and support software and business processes.